THE Living Well, Living Longer (LWLL) integrated breast cancer survivorship ecosystem by innovative healthcare solutions provider Novartis Malaysia, has been recognised across four leading regional industry award platforms in 2026 for its innovative approach to supporting women beyond diagnosis and treatment
Developed in collaboration with clinicians, patient advocacy groups and breast cancer survivors, LWLL brings together three complementary initiatives: the Living Well, Living Longer coffee table book, the ICanCare app and Gift of Time patient workshops.
Together, they provide trusted information, patient navigation and psychosocial support through a connected survivorship ecosystem designed for Malaysian women.
LWLL was developed in response to the growing need for more coordinated survivorship support in Malaysia where many women continue to face challenges accessing reliable information and psychosocial care after treatment.
By connecting educational resources, digital support and community engagement within a single ecosystem, the programme complements clinical care and helps women navigate life with greater confidence.
Since its launch, the initiative has recorded more than 6,000 ICanCare app downloads, achieved over 50% active user engagement, contributed to a 250% increase in demand for psychosocial support and driven a 133% year-on-year increase in Gift of Time workshop bookings, a reflection of growing demand for coordinated survivorship support.
“A breast cancer diagnosis changes far more than a patient’s treatment plan. Many women continue to navigate emotional, practical and informational challenges long after treatment ends,” commented Novartis Malaysia, Brunei and Asia Emerging Markets (AEM) country president Sanjeev Balachandran.
“Living Well, Living Longer was created to ensure they (breast cancer patients) have access to trusted guidance and support throughout that experience.”
Honoured that such effort has been recognised across several regional award platforms, Sanjeev added:
“More importantly, it reinforces the importance of long-term collaboration between healthcare professionals, patient advocacy groups and industry to strengthen survivorship support for women living with breast cancer, hence helping improve and extend patients’ lives.”
The recognition spans patient advocacy, healthcare communications and purpose-driven storytelling across four regional award programmes. namely:
Healthcare Asia Pharma Awards 2026 which encompass
- Marketing & Communications Initiative of the Year – Malaysia
- Patient Advocacy Programme of the Year – Malaysia
Marketing-Interactive PR Awards Southeast Asia 2026
- Silver: Best Event-Led PR Campaign
- Silver: PR Team of the Year (Brand)
- Bronze: Best PR Campaign: Healthcare & Pharmaceuticals
Public Relations & Communications Association of Malaysia (PRCA) Asia-Pacific Awards 2026
- Game Changer Award
Content Marketing Awards Asia Pacific 2026
- Gold: Best Content Campaign for Advocacy & Community Building
- Silver: Best Content Campaign in Healthcare & Pharmaceuticals
- Bronze: Best Purpose-Driven Content Campaign – Aug 8, 2026
